The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3 , Pages 495-502 , March 2008

Bleeding in cardiac surgery: The use of aprotinin does not affect survival

  • Domenico Pagano, MD, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • Corresponding Author InformationAddress for reprints: D. Pagano, MD, FRCS, Department Cardiothoracic Surgery, University Hospital Birmingham, Edgbaston, Birmingham B15 2TH, United Kingdom.
    • ,
  • Neil J. Howell, FRCS

      Affiliations

    • Health Care Evaluation Group, University of Birmingham, Birmingham, United Kingdom
    • ,
  • Nick Freemantle, PhD

      Affiliations

    • Health Care Evaluation Group, University of Birmingham, Birmingham, United Kingdom
    • ,
  • David Cunningham, PhD

      Affiliations

    • NHS Health and Social Services Information Centre, Leeds, United Kingdom
    • ,
  • Robert S. Bonser, MD, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Timothy R. Graham, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Jorge Mascaro, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Stephen J. Rooney, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Ian C. Wilson, MD, FRCS

      Affiliations

    • Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Rob Cramb, FRCPath

      Affiliations

    • Department of Clinical Biochemistry, University Hospital Birmingham, Birmingham, United Kingdom
    • ,
  • Bruce E. Keogh, MD, FRCS

      Affiliations

    • National Institute for Clinical Outcomes Research, University College London, London, United Kingdom

Received 20 July 2007 ,Revised 16 October 2007 ,Accepted 8 November 2007.

References 

  1. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, et al. Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg. 1998;133:442–447
  2. Keogh B, Kinsman R. Fifth National Adult Cardiac Surgical Database Report 2003. Reading (United Kingdom): Deandrite Clinical Systems; 2004;
  3. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004;128:442–448
  4. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;2:1289–1291
  5. Fergusson D, Glass KC, Hutton B, Shapiro S. Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?. Clin Trials. 2005;2:218–232
  6. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801–2813
  7. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353–365
  8. Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471–479
  9. Cockroft D, Gault M. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  10. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13
  11. Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005;112(suppl):I270–I275
  12. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
  13. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203
  14. Young C, Horton R. Putting clinical trials into context. Lancet. 2005;366:107–108
  15. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg. 1993;55:971–976
  16. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650–1657
  17. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608–1616
  18. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg. 2002;74:1180–1186
  19. Toumpoulis IK, Anagnostopoulos CE, Toumpoulis SK, DeRose JJ, Swistel DG. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg. 2005;79:1902–1908
  20. Toumpoulis IK, Anagnostopoulos CE, DeRose JJ, Swistel DG. European system for cardiac risk evaluation predicts long-term survival in patients with coronary artery bypass grafting. Eur J Cardiothorac Surg. 2004;25:51–58
  21. De Maria R, Mazzoni M, Parolini M, Gragory D, Bortone F, Arena V, et al. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study. Heart. 2005;91:779–784
  22. Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg. 1994;107:1489–1495
  23. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158–1162
  24. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–348
  25. Stallwood MI, Grayson AD, Mills K, Scawn ND. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg. 2004;77:968–972
  26. Lemmer JH, Stanford W, Bonney SL, Chomka EV, Karp RB, Laub GW, et al. Aprotinin for coronary artery bypass grafting: effect on postoperative renal function. Ann Thorac Surg. 1995;59:132–136
  27. Brown JR, Cochran RP, Dacey LJ, Ross CS, Kunzelman KS, Dunton RF, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation. 2006;114(suppl):I409–I413
  28. Royston D, van Haaften N, De Vooght P. Aprotinin; friend or foe? A review of recent medical literature. Eur J Anaesthesiol. 2007;24:6–14
  29. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettila V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81:542–546
  30. Bucerius J, Gummert JF, Walther T, Schmitt DV, Doll N, Falk V, et al. On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy. Ann Thorac Surg. 2004;77:1250–1256

 Neil Howell and Domenico Pagano report lecture fees from Bayer.

PII: S0022-5223(08)00070-6

doi: 10.1016/j.jtcvs.2007.11.045

The Journal of Thoracic and Cardiovascular Surgery
Volume 135, Issue 3 , Pages 495-502 , March 2008

Article Tools

* Image Usage & Resolution